Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2016.00112
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

P1.01-52 BR-34- Randomized Trial of Durvalumab and Tremelimumab +/- Platinum Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine
2018English

P1.01-104 Updated Phase I Results of Carboplatin, Pemetrexed and Exemestane in Postmenopausal Women With Metastatic Non-Squamous NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer

Mini-Reviews in Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2016English

Pcn34 - Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-Squamous NSCLC – A Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

P3.01-09 Impact of Urban or Rural Residence on Overall Survival for Patients With Metastatic Non-Squamous NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Advances in the Therapeutics of Antimony

Books Abroad
1939English

Recent Advances in Pancreatology

Frontiers in Physiology
Physiology
2014English

Recent Advances in Seismocardiography

Vibration
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy